Buchumschlag

Netupitant-palonosetron (NEPA) for preventing chemotherapy-induced nausea and vomiting: from clinical trials to daily practice

Chemotherapy-induced nausea and vomiting (CINV) is a common adverse event associated - with many anticancer therapies and can negatively impact patients' quality of life and potentially - limit the effectiveness of chemotherapy. Currently, CINV can be prevented in most patients with - guideline...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Aapro, Matti S. (VerfasserIn) , Jordan, Karin (VerfasserIn) , Scotté, Florian (VerfasserIn) , Celio, Luigi (VerfasserIn) , Karthaus, Meinolf (VerfasserIn) , Roeland, Eric (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 18 July, 2022
In: Current cancer drug targets
Year: 2022, Jahrgang: 22, Heft: 10, Pages: 806-824
ISSN:1873-5576
DOI:10.2174/1568009622666220513094352
Online-Zugang:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.2174/1568009622666220513094352
Verlag, lizenzpflichtig, Volltext: https://www.eurekaselect.com/article/123486
Volltext
Verfasserangaben:Matti Aapro, Karin Jordan, Florian Scotté, Luigi Celio, Meinolf Karthaus and Eric Roeland
Beschreibung
Zusammenfassung:Chemotherapy-induced nausea and vomiting (CINV) is a common adverse event associated - with many anticancer therapies and can negatively impact patients' quality of life and potentially - limit the effectiveness of chemotherapy. Currently, CINV can be prevented in most patients with - guideline-recommended antiemetic regimens. However, clinicians do not always follow guidelines, - and patients often face difficulties adhering to their prescribed treatments. Therefore, approaches to - increase guideline adherence need to be implemented.
Beschreibung:Gesehen am 10.01.2023
Beschreibung:Online Resource
ISSN:1873-5576
DOI:10.2174/1568009622666220513094352

Ähnliche Einträge